Biomatrica specializes in developing advanced sample preservation technologies for the collection and analysis of biomarkers. The company serves clients in the healthcare and biotechnology sectors, focusing on applications such as cancer screening, non-invasive prenatal testing (NIPT), and gene expression analysis. Operating within the global market, Biomatrica's business model revolves around providing cutting-edge solutions that ensure the integrity and stability of biological samples during transportation and storage. Revenue is generated through the sale of proprietary blood collection tubes and other preservation devices, which are designed to capture circulating free DNA, RNA, and cells. Biomatrica's robust technology and scientific support have been pivotal in the successful implementation of their products in various clinical trials, addressing pre-analytical variance issues. As a wholly owned subsidiary of Exact Sciences Corp., Biomatrica continues to innovate and expand its biomarker collection portfolio, maintaining a strong reputation for reliability and collaboration.

Keywords: sample preservation, biomarker collection, cancer screening, NIPT, gene expression, biological samples, healthcare, biotechnology, clinical trials, Exact Sciences.